Thomas J. Polascik, MD, Duke University, Durham, North Carolina, discusses the barriers to focal therapy becoming more widely accepted for prostate cancer.
Interview produced by Prostatepedia
Keywords: focal therapy, clinical trials, prostate cancer
Exercise & Wellness
Fred Bartlit, Esq.
StrongPath
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan